Abstract
Hematopoiesis represents a dynamic example of tissue homeostasis in which cells undergo constant cell proliferation and death. In the normal physiological condition, a small fraction of blood cells are steadily removed from the body and replaced by new cells generated from the bone marrow, the site of human hematopoiesis. This normal turnover is maintained by a balance between the rates of proliferation and renewal of progenitor cells and the rate of death of more differentiated cells. With the loss of mature blood cells the number of functional cells decreases and pluripotent progenitors supply their replacements through proliferation and differentiation into mature cells. In certain “stress” conditions, the bone marrow can expand a specific sub-population of hematopoietic cells to more than ten times of its normal level. When such an increased physiological demand exists, specific cell types have “unbalanced” rates of proliferation and death, such that the death rate is decreased relative to the proliferation rate and expansion of the specific population results. As the expanding cell population reaches the point of meeting the increased demand, the drive for expansion subsides. Then the death rate is increased relative to the proliferation rate until the cell number returns to that of the normal basal homeostasis. The balance between proliferation and death is partially regulated by availability of soluble hematopoietic growth factors. Because blood cells can mediate various inflammatory reactions, extensive turnover and expansion of hematopoietic cells occur during inflammatory states.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bondurant M, Koury MJ (1998) Origin and development of blood cells. In: Lee GR, Foerster J, Greer JP, Lukens JN, Rodgers G, Paraskevas F (eds): Wintrobe’s clinical hematology, 10th edition. Williams and Wilkins, Baltimore, 145–168
Ogawa M (1993) Differentiation and proliferation of hematopoietic stem cells. Blood 81: 2844–2853
Tilg H, Peschel C (1996) Interferon-alpha and its effects on the cytokine cascade: a proand anti-inflammatory cytokine. Leuk Lymphoma 23: 55–60
Cook DN (1996) The role of MIP-1-alpha in inflammation and hematopoiesis. J Leukocyte Biol 59: 61–66
Bertero MT, Caligaris-Cappio F (1997) Anemia of chronic disorders in systemic autoimmune diseases. Haematologica 82: 375–381
Metcalf D (1993) Hematopoietic regulators: Redundancy or subtlety? Blood 82: 3515–3523
Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 87: 2162–2170
Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR (1994) Mice lacking granulocyte colony stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor deficiency, and impaired neutrophil mobilization. Blood 84: 1737–1746
Nishinakamura R, Miyajima A, Mee PJ, Tybulewicz VU, Murray R (1996) Hematopoiesis in mice lacking the entire granulocyte-macrophage clonony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 88: 2458–2464
Schwarzmeier JD (1996) The role of cytokines in haematopoiesis. Eur J Haematol 57: 69–74
Nagata Y, Moriguchi T, Nishida E, Todokoro K (1997) Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood 90: 929–934
Penta K, Sawyer ST (1995) Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT-1 and STAT-5 in erythroid cells. J Biol Chem 270:31282–31287
Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD (1995) The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinase. Exp Hematol 23: 1040–1048
Kieran MW, Perkins AC, Orkin SH, Zon LI (1996) Thrombopoietin rescues erythroid colonies from erythropoietin receptor deficient embryos. Proc Natl Acad Sci USA 93: 9126–9131
Shimizu R, Komatsu N, Nakamura Y, Nakauchi H, Nakalbeppu Y, Miura Y (1996) Role of c-jun in the inhibition of erythropoietin receptor-mediated apoptosis. Biochem Biophys Res Comm 222: 1–6
Sachs L (1996) The control of hematopoiesis and leukemia: from basic biology to the clinic. Proc Natl Acad Sci USA 93: 4742–4749
Lotem J, Shabo Y, Sachs L (1991) The network of hemopoietic regulatory proteins in myeloid cell differentiation. Cell Growth Differ 2: 421–427
Kaushanski K, Lin N, Adamson JW (1988) Interleukin-1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factor. J Clin Invest 81: 92–97
Dan K, Gomi S, Inokuchi K, Ogata K, Yamada T, Ohki I, Hasegawa S, Nomura T (1995) Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thromocytosis. Acta Haematol 93: 67–72
Jacobsen SEMW, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR (1991) Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 77: 1706–1716
Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C (1994) Regulation of cytokine expression by interferon alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of IL-1 receptor antogonist. Blood 83: 4142–4150
Mangan DF, Wahl SM (1991) Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 147: 3408–3412
Selleri C, Sato T, Anderson A, Young NS, Maciejewski JP (1995) Interferon-gamma and tumor necrosis factor-a suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165: 538–546
Nagafuji K, Shibuya T, Harada M, Mizuno S-I, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y (1995) Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86: 883–889
Mangan DF, Robertson B, Wahl SM (1992) IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 148: 1812–1816
Maciejewski JP, Selleri C, Anderson A, Young NS (1995) Fas antigen expression on CD34+human marrow cells is induced by interferon-gamma and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85: 3183–3190
Farrell AJ, Blake DR (1996) Nitric oxide. Ann Rheum Dis 55: 7–20
Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS (1995) Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 96: 1085–1092
Punjabi CJ, Laskin DL, Heck DE, Laskin JD (1992) Production of nitric oxide by murine bone marrow cells: inverse correlation with cellular proliferation. J Immunol 149: 2179–2184
Shami PJ, Weinberg JB (1996) Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells. Blood 87: 977–982
Lee JW, Beckham C, Michel BR, Rosen H, Deeg HJ (1997) HLA-DR-mediated signals for hematopoiesis and induction of apoptosis involve but are not limited to a nitric oxide pathway. Blood 90: 217–225
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin J-J, Garrone P, Garcia E, Saeland S et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopietic cytokines. J Exp Med 183: 2593–2603
Rollins BJ (1997) Chemokines. Blood 90: 909–928
Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY (1983) Comparative analysis of the influcences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131: 1300–1305
Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies B (1995) Requirement of MIP-la for an inflammatory response to viral infection. Science 269: 1583–1585
Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W (1992) CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol 20: 1004–1010
Tushinski RJ, Oliver IT, Gilbert LJ, Tynan PW, Warner JR, Stanley ER (1982) Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28: 71–81
Clutterbuck EJ, Hirst EM, Sanderson CJ (1989) Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 73: 1504–1512
Sonoda Y, Arai N, Ogawa M (1989) Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-5. Leukemia 3: 14–18
Tai PC, Sun L, Spry CJ (1991) Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 85: 312–316
De Andres B, Mueller AL, Blum A, Weinstock J, Verbeek S, Sandor M, Lynch RG (1997) FcrII (CD32) is linked to apoptotic pathways in murine granulocyte precursors and mature eosinophils. Blood 90: 1267–1274
Denburg JA (1992) Basophil and mast cell lineage in vitro and in vivo. Blood 79: 846–860
Sanderson CJ (1992) Interleukin-5, eosinophils and disease. Blood 79: 3101–3109
Sher A, Coffman RL, Hieny S, Scott P, Cheever AW (1990) Interleukin-5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 87: 61–65
Rennick DM, Thompson-Snipes LA, Coffman RL, Seymour BWP, Jackson JD, Hudak S (1990) In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice. Blood 76: 312–316
Dent LA, Strath M, Mellor AL, Sanderson CJ (1990) Eosinophilia in transgenic mice expressing interleukin-5. J Exp Med 172: 1425–1431
Vaux DL, Lalot PA, Cory S, Johnson GR (1990) In vivo expression of interleukin-5 induces an eosinophilia and expanded By-1B lineage populations. Int Immunol 2: 965–971
Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourn EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI (1996) IL-5 deficient mice have a developmental defect in CDS+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell response. Immunity 4: 15–24
Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, Wardlaw AJ, Kay AB (1991) Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 174: 749–752
Broide DH, Paire MM, Firestein GS (1992) Eosinophils express interleukin 5 and granulocyte-macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90: 1414–1424
Alam R, Forsythe P, Stafford S, Fukuda Y (1994) Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 179: 1041–1045
Shull MM, Ormsby L, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D et al (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693–699
Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y (1995) Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86: 883–889
Druilhe A, Cai A, Haile S, Chouaib S, Pretolani M (1996) Fas-mediated apoptosis in cultured human eosinophils. Blood 87: 2822–2830
Koury MJ, Bondurant MC (1988) The maintenance by erythropoietin of viability, proliferation and maturation of murine erythroid precursor cells. J Cell Physiol 137: 65–74
Koury MJ, Bondurant MC (1990) Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248: 378–381
Wu H, Liu X, Jaenisch R, Lodish HF (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83: 59–67
Faquin WC, Schneider TJ, Goldberg MA (1992) Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79: 1987–1994
Dai CH, Krantz SB, Kollar K, Price JO (1995) Stem cell factor can overcome inhibition of highly purified human burst-forming units-erythroid by interferon gamma. J Cell Physiol 165: 323–332
Means RT, Krantz SB (1991) Inhibition of human erythroid colony forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood 78: 2564–2567
Nakao S, Yamaguchi M, Shiobara S, Yokoi T, Miyawaki T, Taniguchi T, Matsuda T (1992) Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 79: 2532–2535
Selleri C, Maciejewski JP, Sato T, Young NS (1996) Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87: 4149–4157
Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryopoiesis in mice lacking the thrombopoietin receptor c-mpl. Blood 87: 2162–2170
Borge OJ, Ransfjell V, Jacobsen SEW (1997) Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38-bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood 90: 2282–2292
Debili N, Coulombel JH, Croisille L, Katz A, Guichard J, Breton-Gorius J, Vainchencker W (1996) Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88: 1284–1296
Fibbe WE, Heemskerk DP, Laterveer L, Pruijt JF, Foster D, Kaushansky K, Willemze R (1995) Accelerated reconstitution of platelets and erythrocytes after synergistic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 86: 3308–3313
Kaushansky K, Broudy VC, Grossmann A, Humes J, Lin N, Ren HP, Bailey MC, Papayannopoulou T, Forstrom JW, Sprugel KH (1995) Thrombopoietin expands erythroid progenitors, increases red cell production and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 96: 1683–1687
Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M (1995) Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythoid progenitors. Blood 86: 2494–2499
Ratajczak MZ, Ratajczak J, Marlicz W, Pletcher CHJ, Machalinski B, Moore J, Hung H-L, Gewirtz AM (1997) Recombinant human thrombopoietin (TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis. Br J Haematol 98: 8–17
Harker LA, Finch CA (1969) Thrombokinetics in man. J Clin Invest 48: 963–974
Odell TT, McDonald TP, Howsden FL (1964) Native and foreign stimulators of platelet production. J Lab Clin Med 64: 418–424
Abildgaard CF, Simone JV (1967) Thrombopoiesis. Semin Hematol 4: 424–452
Zsebo KM, Yushenkoff VN, Schiffer S, Chang D, McCall E, Dinarello CA, Brown MA, Altrock B, Bagby GCJ (1988) Vascular endothelial cells and granulopoiesis: interleukin1 stimulates release of G-CSF and GM-CSF. Blood 71: 99–103
Ku H, Yonemura Y, Kaushansky K, Ogawa M (1996) Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopietic progenitors of mice. Blood 87: 4544–4551
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Park, D.J., Koury, M.J. (1999). Hematopoietic cells. In: Winkler, J.D. (eds) Apoptosis and Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8741-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8741-0_6
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9752-5
Online ISBN: 978-3-0348-8741-0
eBook Packages: Springer Book Archive